candesartan has been researched along with angiotensin a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albiston, AL; Chai, SY; Demaegdt, H; Dupont, AG; Lukaszuk, A; Nahmias, C; Smolders, I; Tourwé, D; Van Eeckhaut, A; Vanderheyden, P; Vauquelin, G; Walther, T; Yang, R | 1 |
1 other study(ies) available for candesartan and angiotensin a
Article | Year |
---|---|
Pressor and renal hemodynamic effects of the novel angiotensin A peptide are angiotensin II type 1A receptor dependent.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensins; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Hypertension; Kidney; Male; Mice; Mice, Knockout; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Renal Circulation; Statistics, Nonparametric; Tetrazoles; Vasoconstriction | 2011 |